Nordic Nanovector ASA (DE:8NN) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Thor Medical ASA has secured a strategic 5-year supply agreement with ARTBIO, valued at up to NOK 400 million, to provide Thorium-228 for pioneering cancer treatments. This partnership marks a significant step for Thor Medical in commercializing large-scale production of alpha-emitters, with plans for a new facility in Norway. The collaboration is set to enhance ARTBIO’s development of novel cancer therapies, highlighting the potential growth in the radiopharmaceutical sector.
For further insights into DE:8NN stock, check out TipRanks’ Stock Analysis page.
